Maurizio Fanciulli

18PUBLICATIONS
86CO-AUTHORS
Molecular targetsCancer cell biologyMedical infection agents (incl. prions)Metabolic medicinePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 15, 2026
Intratumoral Immune Heterogeneity Drives Divergent Outcomes to PD-(L)1 Blockade in Lung Cancer.

|Mar 24, 2026
AATF supports proliferation of glioblastoma cells by sustaining mitochondrial respiration through an NRF-1-dependent mechanism.

Cristina Sorino, Stefano Di Giovenale, Italia Falcone

|Nov 28, 2025
Dissecting endometrial cancer complexity in response to standard and targeted therapies.

Sebastiano Vaccarella, Valentina Bruno, Giulia Orlandi

|Sep 08, 2025
Nuclear respiratory factor 1 promotes cell survival in multiple myeloma under proteasome inhibition therapy.

Tiziana Bruno, Maria Chiara Cappelletto, Clelia Cortile

|Jun 27, 2025
Metabolic Reprogramming in Melanoma: An Epigenetic Point of View.

Stefano Giuliani, Celeste Accetta, Simona di Martino

|Jul 09, 2024
Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy.

Stefano Scalera, Biagio Ricciuti, Daniele Marinelli

Pageof 3

Frequent Collaborators

6 joint publications

Giovanni Blandino

5 joint publications

Ludovica Ciuffreda

4 joint publications

Gennaro Ciliberto

4 joint publications

Italia Falcone